What is the address of MediXS?

The registered office of MediXS is located at Boslaan 1, 3050 Oud-Heverlee.

Is MediXS still active?

Yes. According to the CBE (30 October 2026) MediXS is active, legal situation “Normale toestand”, started on 20 November 2017.

Is MediXS registered on Peppol?

No, MediXS is currently not registered on the Peppol network.

What is the enterprise number of MediXS?

The enterprise number of MediXS is BE0684828512.

When was MediXS founded?

MediXS was founded on 20 November 2017.

Who are the directors of MediXS?

According to the 2025 annual accounts, the directors of MediXS are: Jeannine Bauwens, Daniel Jaspart.

Is MediXS a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 20 November 2017; 5 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account.

How much profit did MediXS make in 2025?

MediXS recorded a loss after taxes of € 24,534 in financial year 2025.

What is the revenue of MediXS?

As a small company, MediXS is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € -15,652.

MediXS (Private Limited) - Oud-Heverlee - BE0684828512

Dossier MediXS, printed on 30 October 2026 from databakkes.be/en/0684828512/medixs. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Not on Peppol Peppol

Not registered in the Peppol network, mandatory for VAT-liable companies since 1 January 2026.

Financials

Financial year 2025

MediXS from Oud-Heverlee, company number BE0684828512, closed financial year 2025 with a result of € -24,534 after tax. For that financial year MediXS recorded a gross margin of € -15,652 and equity of € 167,088. Compared with financial year 2024, the result moved from € 9,247 to € -24,534. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on October 14, 2026.

What it is worth Healthy

€ 167,088

▼ 13% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Loss Caution

€ -24,534

▼ still € 9,247 profit in 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 181,851

▲ 124% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Caution

Loss, nothing to pay out

Reserves fell to € 154,688.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 1,115

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 1,040

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 13,756 Gross margin 2022: € 13,756 First fiscal year in the series	€ 21,149 Gross margin 2023: € 21,149 ▲ 54% vs 2022 (€ 13,756) Favourable step	€ 22,896 Gross margin 2024: € 22,896 ▲ 8% vs 2023 (€ 21,149) Favourable step	€ -15,652 Gross margin 2025: € -15,652 ▼ € 38,548 vs 2024 (€ 22,896) Unfavourable step	▼ € 38,548
Profit after taxes	€ 10,129 Profit after taxes 2022: € 10,129 First fiscal year in the series	€ 6,806 Profit after taxes 2023: € 6,806 ▼ 33% vs 2022 (€ 10,129) Unfavourable step	€ 9,247 Profit after taxes 2024: € 9,247 ▲ 36% vs 2023 (€ 6,806) Favourable step	€ -24,534 Profit after taxes 2025: € -24,534 ▼ € 33,781 vs 2024 (€ 9,247) Unfavourable step	▼ € 33,781
Equity	€ 175,569 Equity 2022: € 175,569 First fiscal year in the series	€ 182,375 Equity 2023: € 182,375 ▲ 4% vs 2022 (€ 175,569) Favourable step	€ 191,622 Equity 2024: € 191,622 ▲ 5% vs 2023 (€ 182,375) Favourable step	€ 167,088 Equity 2025: € 167,088 ▼ 13% vs 2024 (€ 191,622) Unfavourable step	▼ 13%
Total debts	€ 27,952 Total debts 2022: € 27,952 First fiscal year in the series	€ 25,590 Total debts 2023: € 25,590 ▼ 8% vs 2022 (€ 27,952) Favourable step	€ 10,499 Total debts 2024: € 10,499 ▼ 59% vs 2023 (€ 25,590) Favourable step	€ 14,763 Total debts 2025: € 14,763 ▲ 41% vs 2024 (€ 10,499) Unfavourable step	▲ 41%
Cash	€ 43,434 Cash 2022: € 43,434 First fiscal year in the series	€ 61,916 Cash 2023: € 61,916 ▲ 43% vs 2022 (€ 43,434) Favourable step	€ 81,253 Cash 2024: € 81,253 ▲ 31% vs 2023 (€ 61,916) Favourable step	€ 181,851 Cash 2025: € 181,851 ▲ 124% vs 2024 (€ 81,253) Favourable step	▲ 124%
Land & buildings	€ 119,123 Land & buildings 2022: € 119,123 First fiscal year in the series	€ 114,921 Land & buildings 2023: € 114,921 ▼ 4% vs 2022 (€ 119,123) Unchanged	€ 110,719 Land & buildings 2024: € 110,719 ▼ 4% vs 2023 (€ 114,921) Unchanged	-
Retained profit	€ 163,169 Retained profit 2022: € 163,169 First fiscal year in the series	€ 169,975 Retained profit 2023: € 169,975 ▲ 4% vs 2022 (€ 163,169) Favourable step	€ 179,222 Retained profit 2024: € 179,222 ▲ 5% vs 2023 (€ 169,975) Favourable step	€ 154,688 Retained profit 2025: € 154,688 ▼ 14% vs 2024 (€ 179,222) Unfavourable step	▼ 14%
Balance sheet total	€ 203,521 Balance sheet total 2022: € 203,521 First fiscal year in the series	€ 207,965 Balance sheet total 2023: € 207,965 ▲ 2% vs 2022 (€ 203,521) Unchanged	€ 202,121 Balance sheet total 2024: € 202,121 ▼ 3% vs 2023 (€ 207,965) Unchanged	€ 181,851 Balance sheet total 2025: € 181,851 ▼ 10% vs 2024 (€ 202,121) Unchanged	▼ 10%

Key figures of MediXS, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to MediXS?

What happened at MediXS in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Oct 14, 2026 New annual accounts for financial year 2025: loss of € 24,534 (▼ € 33,781 vs 2024). filed late Source: NBB ↗
Nov 20, 2017 Start of the company according to the CBE. KBO

In short

From € 10,129 profit in 2022 to € 24,534 loss in 2025.

Paid € 4,979 in corporate taxes since 2022.

Best year ever: 2022, with € 10,129 profit.

Original PDFs at the National Bank ↗

Management

Jeannine Bauwens Daniel Jaspart

MediXS

Behind MediXS are Jeannine Bauwens and Daniel Jaspart.

Directors

According to the 2025 annual accounts

Jeannine Bauwens

Director

Daniel Jaspart

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Boslaan 1

3050 Oud-Heverlee

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0684.828.512
VAT number: BE 0684.828.512
Registered office: Boslaan 1, 3050 Oud-Heverlee
Names & denominations: MediXS
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 20 November 2017
Peppol: Not registered
Contact: medixs.be [email protected]

View on CBE Public ↗ Annual accounts (NBB) ↗